Treatment outcome of patients with comorbid type 1 diabetes and eating disorders

Background: Co-morbidity between Type 1 Diabetes Mellitus (T1DM) and eating disorders (ED) has been previously described; however the effect of this illness on the outcomes for conventional ED treatments has not been previously investigated. This study aims to compare clinical, psychopathological an...

Descripción completa

Detalles Bibliográficos
Autores: Custal, Nuria, Arcelus, Jon, Agüera, Zaida, Bove, Francesca, Wales, Jackie, Granero, Roser, Jiménez-Murcia, Susana, Sánchez Zaplana, Isabel, Riesco, Nadine, Alonso Ortega, María del Pino, Crespo, J. M. (José Manuel), Virgili, Núria, Menchón Magriñá, José Manuel, Fernández Aranda, Fernando
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2014
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/113789
Acceso en línea:https://hdl.handle.net/2445/113789
Access Level:acceso abierto
Palabra clave:Diabetis
Comorbiditat
Trastorns de la conducta alimentària
Psicopatologia
Insulina
Avaluació de resultats (Assistència mèdica)
Diabetes
Comorbidity
Eating disorders
Pathological psychology
Insulin
Outcome assessment (Medical care)
Descripción
Sumario:Background: Co-morbidity between Type 1 Diabetes Mellitus (T1DM) and eating disorders (ED) has been previously described; however the effect of this illness on the outcomes for conventional ED treatments has not been previously investigated. This study aims to compare clinical, psychopathological and personality features between two samples of ED individuals: those with comorbid T1DM and those without (No-DM); and to identify differences in treatment outcomes between the groups. Methods: This study compares treatment outcome, dropouts, ED psychopathology and personality characteristics for 20 individuals with ED and T1DM and 20 ED patients without diabetes, matched for diagnostic and treatment type. Results: The study found higher dropout rates from therapy in individuals with T1DM and worse treatment outcome in spite of having no significant differences in eating disorder psychopathology, although individuals with T1DM report misusing insulin. Conclusions: The low levels of motivation to change, and insulin abuse in T1DM patients, may suggest that treatment for patients with ED and T1DM should consider the individual's personality and role of insulin abuse when determining the appropriate intervention.

Similares en LA Referencia